Beckley Psytech is at the forefront of the psychedelic medicine industry, specializing in the development and exploration of transformative therapies. As a pioneering psychedelic medicine company, our primary focus lies in creating a robust drug pipeline consisting of psychedelic medicines. We firmly believe that these medicines hold immense commercial potential in addressing unmet clinical needs. Through our groundbreaking research and development efforts, we aim to unlock the therapeutic power of psychedelics and revolutionize the treatment landscape. At Beckley Psytech, we are committed to pushing the boundaries of medicine to provide innovative solutions for those in need.
$186M • 2020 • Series A
At Beckley Psytech, our unwavering commitment is to push the limits of medicine, delivering groundbreaking and innovative solutions for individuals in need.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
No spam. Up to 2 emails/mo – only the good stuff!